טוען...
Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways
Non-small-cell lung cancer (NSCLC) is the third most common cancer that spreads to the bone, resulting in osteolytic lesions caused by hyperactivation of osteoclasts. Activating mutations in epidermal growth factor receptor-tyrosine kinase (EGF-TK) are frequently associated with NSCLC, and afatinib...
שמור ב:
| הוצא לאור ב: | BMB Rep |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Society for Biochemistry and Molecular Biology
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5422028/ https://ncbi.nlm.nih.gov/pubmed/28256196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2017.50.3.223 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|